Skip to main content

Pulling Out Proteins

Troubleshooting discovery and validation of protein biomarkers for cancer.

Written byKelly Rae Chi
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00

Researchers have long pinned hopes on biological indicators—or molecular biomarkers—to serve as tools to help clinicians identify populations at risk, classify tumor types, or monitor disease progression in cancer, which is diagnosed in an estimated 11 million people worldwide each year. Genes have held the spotlight for many years as potential biomarkers of cancer, but increasingly, researchers are turning to individual proteins or groups of proteins and their modifications with the belief that these molecules hold secrets to cancer pathophysiology.

Because protein modifications can be extremely diverse (leading to a large number of isoforms) and proteins cannot be amplified like DNA can, they don't always offer a clear molecular distinction between a cancer patient and healthy control. "There are several difficulties in the study of proteins that are not inherent in the study of nucleic acids," writes William Cho, a scientific officer in clinical oncology at Queen Elizabeth Hospital in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Published In

Related Topics

November digest cover
November 2026

Chemistry Meets Arcade Combat in “Reaction Rumble” Game

Choose your fighter! Enter the arena as chemical elements and dole out moves inspired by real-world reactions in this educational browser-based game.

View this Issue
Thumbnail

Make It Local, Make It Last: The Evolution of mRNA Protein Replacement Therapy

Improving Western Blot Analysis of Biofluid Samples

Improving Western Blot Analysis of Biofluid Samples

Bio-Rad
Reducing AAV Sample Consumption With Multiwavelength SV-AUC

Reducing AAV Sample Consumption With Multiwavelength SV-AUC

​Beckman Coulter
Optimizing SV-AUC for Peptide Therapeutic Analysis

Optimizing SV-AUC for Peptide Therapeutic Analysis

​Beckman Coulter

Products

Sino Biological Logo

Sino Biological Advances AI-Designed Molecule Validation with 4RISE™

Abstract image of circles and concentric lines on a blue and pink background.

MX Analytical and Precision Balances: Effortless Weighing and Secure Data Handling

Mettler
3D multicolored conceptual image of antibody molecules

Premium BsAb: LC-MS-Assisted Bispecific Antibody Production with >98% Heterodimer Purity

WuXi Biologics
Abstract conceptual image of AI technology for medical science research.

Exploring a New Era of Pharmaceutical Innovation